Association for Molecular Pathology v. Myriad Genetics, Inc.

GPTKB entity

Predicate	Object
gptkbp:instanceOf	gptkb:United_States_Supreme_Court_case
gptkbp:alsoKnownAs	gptkb:Myriad_Genetics_case
gptkbp:arguedDate	April 15, 2013
gptkbp:citation	gptkb:569_U.S._576
gptkbp:country	gptkb:United_States
gptkbp:date	June 13, 2013
gptkbp:decision	unanimous decision
gptkbp:docketNumber	12-398
gptkbp:heldBy	Naturally occurring DNA sequences cannot be patented cDNA is patent eligible because it is not naturally occurring
https://www.w3.org/2000/01/rdf-schema#label	Association for Molecular Pathology v. Myriad Genetics, Inc.
gptkbp:judge	gptkb:Supreme_Court_of_the_United_States
gptkbp:opinionBy	gptkb:Justice_Clarence_Thomas
gptkbp:petitioner	gptkb:Association_for_Molecular_Pathology
gptkbp:predecessor	gene patenting cases
gptkbp:relatedTo	gptkb:BRCA1_gene gptkb:BRCA2_gene
gptkbp:response	gptkb:Myriad_Genetics,_Inc.
gptkbp:subject	gptkb:US_patent gptkb:biotechnology genetics
gptkbp:bfsParent	gptkb:Diamond_v._Chakrabarty gptkb:133_S._Ct._1761 gptkb:Mayo_Collaborative_Services_v._Prometheus_Laboratories,_Inc.
gptkbp:bfsLayer	7